Corporate Charity – Is The Gates Foundation Addressing Or Reinforcing Systemic Problems Raised By CO

By Rohit Malpani, Brook Baker & Mohga Kamal-Yanni

Two competing approaches to promote access to medicines were born during the HIV/AIDS pandemic in the year 2000. Today, at the height of the COVID-19 pandemic, these same approaches are once more on a collision course.

https://healthpolicy-watch.news/gates-foundation-address-systemic-covid-19/

Recent Posts

See All

The WTO leaked text : What comes first: public health or commercial interest?

By mid 1990, new medicines to treat HIV became a reality and people living with the virus in the North had their lives turned around. However, people in the South, where most of the infection was, wer

Debate in the bmj: Should covid-19 vaccines and drugs be not-for-profit?

I participated in a debate at The British medical Journal (bmj) on access to medical technologies at the time of pandemic. I argued that governments should take control and that left to pharmaceutical

From claps to cuts!

Access 2 HealthCare

Corporate Charity – Is The Gates Foundation Addressing Or Reinforcing Systemic Problems Raised By CO

Recent Posts

Join My Mailing List